Sign in

Christopher Graber

@idsensei.bsky.social
1.8K followers 121 following 105 posts

ID doc, steward, dad, fellowship program director

PostsRepliesMedia
Reposted by Christopher Graber
Paul Sax @paulsaxmd.bsky.social · 03/04/2026
One-month treatment for latent tuberculosis. Why aren't we using it? (Hint: We should.) voices.nejm.org/doi/full/10....
voices.nejm.org
One-Month Treatment for Latent Tuberculosis
Why aren’t we using it?
32313
Reposted by Christopher Graber
IDSA @idsainfo.bsky.social · 30/03/2026
On IDSA’s & HIVMA’s Science Speaks blog: A study in CID looked at clinical features and predictors of mortality for Legionella pneumonia across a large integrated health system. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA: bit.ly/3NOpG4M
bit.ly
Troubled waters: Legionella pneumonia in the modern era
A study in CID looked at clinical features and predictors of mortality for Legionella pneumonia. Read IDSA's Journal Club review by Christopher J. Graber, MD, MPH, FIDSA.
002
Reposted by Christopher Graber
Joseph Marcus @josephmarcusid.medsky.social · 28/03/2026
Should ID provide primary care to patients with HIV? Point and counter point in @cidjournal.bsky.social Work with primary care for PLWH: doi.org/10.1093/cid/... Work as primary care for PLWH: doi.org/10.1093/cid/... #IDSky
doi.org
Providing the Best Infectious Diseases and Primary Care to Our Patients With HIV: Time for Delivery Models to Evolve
Advances in care for patients with human immunodeficiency virus have simplified the management of infectious disease–related conditions, yet primary care h
094
Christopher Graber @idsensei.bsky.social · 27/03/2026
the counterpoint: academic.oup.com/cid/advance-...
academic.oup.com
Staying in the Tent: Why Infectious Disease Physicians Remain Essential to Human Immunodeficiency Virus Primary Care
Infectious disease (ID) specialists provide consolidated, patient-centered HIV primary care. Workforce shortages, patient preferences, and regional HIV dis
000
Christopher Graber @idsensei.bsky.social · 27/03/2026
Would love to spark a discussion with our recent point-counterpoint in CID on the future of ID-HIV primary care. My colleagues and I argue that we AND our patients are better off leaving the intricacies of primary care to those who do it more than we do. academic.oup.com/cid/advance-...
academic.oup.com
Providing the Best Infectious Diseases and Primary Care to Our Patients With HIV: Time for Delivery Models to Evolve
Advances in care for patients with human immunodeficiency virus have simplified the management of infectious disease–related conditions, yet primary care h
161
Christopher Graber @idsensei.bsky.social · 20/03/2026
Congrats to the incoming class! Where can the fellowship PDs request their baseball cards?
000
Christopher Graber @idsensei.bsky.social · 13/03/2026
does this work? airtable.com/appzPcoBRgsm...
airtable.com
Airtable | Everyone's app platform
Airtable is a low-code platform for building collaborative apps. Customize your workflow, collaborate, and achieve ambitious outcomes. Get started for free.
100
Christopher Graber @idsensei.bsky.social · 12/03/2026
priority list signup for non-US physicians and non-physician folks in healthcare: airtable.com/appzPcoBRgsmUX…
airtable.com
100
Christopher Graber @idsensei.bsky.social · 12/03/2026
what I like about Roon so far: 1. More back-and-forth discussion 2. Ability to follow certain topics in “spaces” (e.g., AI in medicine, health policy, med ed, medical reasoning) 3. You can’t tell how many followers you have (less clout-chasing and virtue signaling) 4. No bots or trolls
020
Christopher Graber @idsensei.bsky.social · 12/03/2026
100% biggest limitation right now. Hopefully temporary (remember when Bluesky was invite-only?)
000
Christopher Graber @idsensei.bsky.social · 12/03/2026
So far it’s limited to US-based physicians (need NPI) but goal is to add others (need our ID pharmacists and international colleagues!) over time
100
Christopher Graber @idsensei.bsky.social · 12/03/2026
Join here! www.roon.com?utm_campaign...
roon.com
Roon for Medical Experts
Where the world’s best physicians share knowledge and advance medicine—together.
100
Christopher Graber @idsensei.bsky.social · 12/03/2026
Remember the glory days of #IDTwitter? Want to have discussions with your colleagues without sifting through the slop of X and the echo chambers of Bluesky? Come join what we are building over at Roon!
210
Christopher Graber @idsensei.bsky.social · 20/02/2026
Bruin. Doin’ us proud.
000
Christopher Graber @idsensei.bsky.social · 19/02/2026
Are you an ID pharmacist currently in the VA system who wants to live in an awesome city and work with awesome people? Look no further. www.usajobs.gov/job/858066800
usajobs.gov
USAJOBS connects job seekers with federal jobs across the United States and around the world as the official employment site for the federal government
The Clinical Pharmacist Specialist for Infectious Diseases must be a licensed pharmacist, have expert knowledge of infectious disease/antimicrobial medication therapy and management, and have an exper...
000
Christopher Graber @idsensei.bsky.social · 18/02/2026
My latest for IDSA Journal Club: a review of a recent CID paper that finds similar outcomes in CAP patients with pos viral testing when treated with 0-2d vs 5-7d abx, adding fuel to recent IDSA-ATS controversy. www.idsociety.org/science-spea...
idsociety.org
Antibiotics in community-acquired pneumonia when respiratory viruses are detected: Adding more fuel to the fire?
A study in CID examined associations between antibiotic use and outcomes in patients hospitalized with community-acquired pneumonia and positive respiratory viral assays.
010
Christopher Graber @idsensei.bsky.social · 13/02/2026
just referred to a smoldering leukocytosis as “low-key” on rounds today…not sure if I’m chopped, cringe, or goated
220
Christopher Graber @idsensei.bsky.social · 09/01/2026
I did not have @mmpharmd.bsky.social making a 6-7 reference in a CID article on my bingo card of things that were going to make my day today but here we are academic.oup.com/cid/advance-...
academic.oup.com
Validate User
141
Christopher Graber @idsensei.bsky.social · 17/12/2025
did ABIM really just send me my LKA Wrapped?
000
Christopher Graber @idsensei.bsky.social · 16/12/2025
we’re talkin’ CloCeBa at @idsainfo.bsky.social Journal Club this month! Do we need to think about adding blaZ type to rapid diagnostic panels for MSSA bacteremia? www.idsociety.org/science-spea...
idsociety.org
Anti-staphylococcal penicillins versus cefazolin for methicillin-susceptible S. aureus bacteremia: Is there a role for determining blaZ type?
A study in The Lancet addressed cloxacillin versus cefazolin for methicillin-susceptible S. aureus bacteremia. Read IDSA’s Journal Club review by Christopher J. Graber.
011
Christopher Graber @idsensei.bsky.social · 01/12/2025
The 6 “coms” of why we are losing the battle over public health: complacency, commitment, commercialism, complexity, communication, and comportment www.nejm.org/doi/full/10....
nejm.org
Restoring Confidence in Public Health | NEJM
A confluence of interrelated factors has put past progress in public health at serious risk in the United States. How did we get here, and what can public health professionals do about it?
020
Reposted by Christopher Graber
UW Infectious Disease Fellowship Program @uwidfellowship.bsky.social · 07/11/2025
With UW’s Dr Paul Pottinger and others, new discussion re: fostering ID advocacy in ID fellowship. They note: Policies with a negative impact on ID clinical care, public health, & research underscore the importance of mobilizing the field of ID to advocacy academic.oup.com/ofid/advance... #IDSky
academic.oup.com
Amplifying Our Voices: Fostering Advocacy in Infectious Diseases Fellowship
This white paper, devised from the Infectious Diseases Society of America's National Training Program Director annual meeting, outlines practical strategie
043
Christopher Graber @idsensei.bsky.social · 24/10/2025
5. The Learner (redux): the late career person who no longer has to play hard at the game and is at the meeting for the science and to have awesome dinners with friends. Making it to this stage is the aspirational goal.
000
Christopher Graber @idsensei.bsky.social · 24/10/2025
4. The Leader: the mid to late career person who mostly goes to meet with other key Leaders to plan grants, policies, and initiatives. Only catches a few educational sessions. Comes late and leaves early.
100
Christopher Graber @idsensei.bsky.social · 24/10/2025
3. The Organizer: the midcareer person involved in planning sessions, moderating, leading symposia, getting people to meet who need to meet. Lucky to make it to half the educational stuff they aren’t involved in.
100
Christopher Graber @idsensei.bsky.social · 24/10/2025
2. The Presenter: the trainee or early career person who has a poster or oral presentation, still learns and absorbs most of the meeting, but the presentation is the focus.
100
Christopher Graber @idsensei.bsky.social · 24/10/2025
beginning to realize the stages of @idweek.bsky.social attendance according to career stage: 1. The Learner: the student/resident/fellow that goes to learn and absorb.
120
Christopher Graber @idsensei.bsky.social · 24/10/2025
the day that AI can do schedule-making better than me is the day my work is done as a PD…it’s gonna be a while
110
Reposted by Christopher Graber
Joanna Schaenman, MD, PhD @jschaenmanmd.bsky.social · 24/10/2025
Feeling inspired seeing so many enthusiastic trainees at #IDWeek2025! We have a 2026-27 opening for our 1-year Transplant ID Advanced Training Program at #UCLA, pls reach out with any questions #IDfellow #TxID @idweek.bsky.social #IDSky @ucla-id-fellowship.bsky.social recruit.apo.ucla.edu/JPF10380
recruit.apo.ucla.edu
Transplant Infectious Diseases Career Development Position 2026-2027
University of California, Los Angeles is hiring. Apply now!
187
Christopher Graber @idsensei.bsky.social · 23/10/2025
Well done to all the teams! Time for everyone to start making plans for BugBowl 2026 in DC!
010
Christopher Graber @idsensei.bsky.social · 22/10/2025
Get psyched! Come for the ATL-themed puns, stay for the knowledge!
021
Reposted by Christopher Graber
IDSA @idsainfo.bsky.social · 17/10/2025
On IDSA’s & HIVMA’s Science Speaks blog: Christopher J. Graber, MD, MPH, FIDSA, explores dalbavancin versus standard therapy for completion of treatment of complicated S. aureus bacteremia. bit.ly/4ncqnAt
idsociety.org
DOT-ting i's and crossing t's: More evidence for using long-acting glycopeptides to finish therapy of complicated S. aureus bacteremia
A JAMA study looked at dalbavancin versus standard therapy for completion of treatment of complicated S. aureus bacteremia. Read IDSA's Journal Club review.
062
Christopher Graber @idsensei.bsky.social · 04/10/2025
010
Christopher Graber @idsensei.bsky.social · 29/09/2025
Looking to do some stewardship and/or hospital epi? Join me, @wbranchelliman.bsky.social, and our crew at VA Greater Los Angeles!
151
Christopher Graber @idsensei.bsky.social · 24/09/2025
best admin assistant (and pre-interview Zoom DJ) ever!
030
Reposted by Christopher Graber
Tara Vijayan @nottheogdrv.bsky.social · 04/09/2025
Colleagues- in case this was missed during summer vacation, please share. I just went to the Bowl again last week and saw Yo-Yo Ma and Angelique Kidjo. The Bowl is not the only reason to be in LA....but it is pretty spectacular. Also my ASP team is just the bee's knees.
021
Christopher Graber @idsensei.bsky.social · 13/08/2025
Calling it a showdown would be vastly overstating it. Fun article that notes differences in cocci presentations in CA vs AZ that we think are driven by inherent population and care pattern differences and not anything inherent to immitis vs posadasii academic.oup.com/ofid/article...
academic.oup.com
Comparison of Patients With Coccidioidomycosis in Arizona Versus California: A Commercial Health Insurance Claims Analysis
Abstract. Commercially insured patients with coccidioidomycosis in Arizona (n = 1640) were more likely to have symptoms indicating acute pulmonary disease
010
Christopher Graber @idsensei.bsky.social · 12/08/2025
the marker of a good journal club is that the fellows have already left for clinic and the attendings are still arguing
150
Christopher Graber @idsensei.bsky.social · 09/08/2025
I demand a randomized controlled trial of hiring people who resign back to their prior jobs. The public deserves nothing less.
020
Christopher Graber @idsensei.bsky.social · 04/08/2025
Moderate immunocompromise (even if overly broadly defined) should not buy you vanc + antipseudomonal for CAP: my latest @idsainfo.bsky.social Journal Club review: www.idsociety.org/science-spea...
idsociety.org
Broad-spectrum antibiotics for moderately immunocompromised patients with CAP: An overdone practice
A study in CID examined broad-spectrum antibiotics in moderately immunocompromised patients with community-acquired pneumonia
0125
Christopher Graber @idsensei.bsky.social · 01/08/2025
my fellow just put up a slide in case conference with the “distracted boyfriend” meme for linezolid overtaking clindamycin as the “toxin” drug of choice and never have I been more proud as a program director
020
Christopher Graber @idsensei.bsky.social · 31/07/2025
let’s goooooooooooooo
010
Christopher Graber @idsensei.bsky.social · 22/07/2025
we’ve all been there, right?
060
Christopher Graber @idsensei.bsky.social · 18/07/2025
most men aren’t complicated, it turns out (at least as it pertains to UTI)
271
Christopher Graber @idsensei.bsky.social · 10/07/2025
you’re damn right I’m giving feedback on every internal medicine LKA question I miss as being a bad question
060
Christopher Graber @idsensei.bsky.social · 09/07/2025
good reminder for all the new trainees: antibiotics don’t fix structural abnormalities
010
Christopher Graber @idsensei.bsky.social · 06/07/2025
ID is about so much more than picking the correct antibiotics
031
Reposted by Christopher Graber
IDSA @idsainfo.bsky.social · 02/07/2025
On IDSA’s & HIVMA’s Science Speaks blog: A study in OFID examined the impact of antibiotic duration on gut microbiome composition and antimicrobial resistance. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA. buff.ly/CDwwOlf
idsociety.org
Shorter may be better, but how (and how much better)?
A study in OFID examined the impact of antibiotic duration on gut microbiome composition and antimicrobial resistance.
141
Christopher Graber @idsensei.bsky.social · 27/06/2025
IDSA Journal Club is back, baby! My latest on the perhaps questionable effect of shortening antimicrobial courses of therapy on the gut microbiome: www.idsociety.org/science-spea...
idsociety.org
Shorter may be better, but how (and how much better)?
A study in OFID examined the impact of antibiotic duration on gut microbiome composition and antimicrobial resistance.
031
Christopher Graber @idsensei.bsky.social · 08/06/2025
you and I prepare for talks differently…this morning on my run I decided that my fellowship graduation speech is going to involve a story about how Michael Stipe came up with lyrics for an R.E.M. deep album cut from 1991 and a YouTube video involving a honey badger and I’m gonna wing it from there
120